Dietary phytoestrogen in estrogen replacement therapy
First Claim
1. A pharmaceutical composition for oral delivery comprising a combination of mammalian estrogen and soy-derived phytoestrogen in an amount sufficient to reduce the risk of coronary heart disease and osteoporosis in women.
3 Assignments
0 Petitions
Accused Products
Abstract
Disclosed is a pharmaceutical composition for oral delivery. The composition includes about 1-2 mg mammalian estrogen and about 25-100 mg phytoestrogen. Compositions of the type described above are utilized, for example, in a therapeutic regimen designed to reduce the risk of coronary heart disease and osteoporosis in postmenopausal women. This method comprises the oral administration of a composition comprising a mixture of estrogen and phytoestrogen, the dosages of mammalian estrogen and phytoestrogen being about 1-2 mg, about 25-100 mg, respectively.
-
Citations
19 Claims
- 1. A pharmaceutical composition for oral delivery comprising a combination of mammalian estrogen and soy-derived phytoestrogen in an amount sufficient to reduce the risk of coronary heart disease and osteoporosis in women.
- 8. A method for reducing the risk of coronary heart disease and osteoporosis in women, the method comprising administering orally a combination of mammalian estrogen and soy-derived phytoestrogen in a therapeutically effective amount.
- 14. An estrogen replacement therapy regimen, comprising the oral coadministration of a combination of mammalian estrogen and soy-derived phytoestrogen in a therapeutically effective amount.
Specification